Hospice utilization among gynecologic oncology (GO) patients is associated with payer and primary tumor site

Davis, Mitzie-Ann

488
Hospice utilization among gynecologic oncology (GO) patients is associated with payer and primary tumor site

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

M. A. Davis¹, K. K. Ward², N. R. Shah¹, L. M. Bean¹, C. C. Saenz¹, M. T. McHale¹ and S. C. Plaxe¹
¹UCSD Rebecca and John Moores Cancer Center, La Jolla, CA, ²University of Florida College of Medicine-Jacksonville, Jacksonville, FL

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

488
Hospice utilization among gynecologic oncology (GO) patients is associated with payer and primary tumor site

488 Hospice utilization among gynecologic oncology (GO) patients is associated with payer and primary tumor site

488
Hospice utilization among gynecologic oncology (GO) patients is associated with payer and primary tumor site